PAVmed Inc. 8-K
Research Summary
AI-generated summary
PAVmed Inc. (PAVM) Reports Results for Quarter Ended March 31, 2026
What Happened
On May 15, 2026, PAVmed Inc. (PAVM) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026 and providing a business update. The press release is attached to the Form 8-K as Exhibit 99.1 and is incorporated by reference. The filing also includes Regulation FD disclosure.
Key Details
- Filing date: May 15, 2026 (Form 8-K).
- Period reported: fiscal quarter ended March 31, 2026.
- Disclosure: press release announcing quarterly financial results and business update attached as Exhibit 99.1.
- Regulation FD: company made a Regulation FD disclosure in the same filing.
Why It Matters
This 8-K is the company’s public announcement of its recent quarterly performance and operational progress — the primary source for updated earnings, revenue, cash position and business milestones for that quarter. Investors should review the attached press release (Exhibit 99.1) for the specific financial figures and management commentary, and note the Regulation FD disclosure indicates the company intends material information to be broadly and fairly disclosed.
Loading document...